Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-01-22 @ 12:24 PM
Study NCT ID:
NCT01856257
Status:
TERMINATED
Last Update Posted:
2020-12-17
First Post:
2013-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Conditions & Keywords Data
Conditions: